Evidence map›Paper›PMID 23692315›Full record

ArticleJournal of neurochemistry2013

Development of brainstem 5-HT1A receptor-binding sites in serotonin-deficient mice.

Caitlin A Massey, Gloria Kim, Andrea E Corcoran, Robin L Haynes, David S Paterson, Kevin J Cummings, Susan M Dymecki, George B Richerson, Eugene E Nattie, Hannah C Kinney and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Caitlin A MasseyDepartment of Anesthesiology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Gloria Kim
Andrea E Corcoran
Robin L Haynes
David S Paterson
Kevin J Cummings
Susan M Dymecki
George B Richerson
Eugene E Nattie
Hannah C Kinney
Kathryn G Commons
Harvard University · USBoston Children's Hospital · USDartmouth College · USUniversity of Missouri · USYale University · US

Funding

VENTRAL MEDULLA, BREATHING, AND CENTRAL CHEMORECEPTIONP01HD036379 · NICHD · HARVARD MEDICAL SCHOOL · PI KINNEY, HANNAH CHASE · 1998 to 2017
$32.2M
Topography of Serotonin DysfunctionR01DA021801 · NIDA · BOSTON CHILDREN'S HOSPITAL · PI COMMONS, KATHRYN G · 2007 to 2018
$3.6M
NICHD NIH HHS P01 HD-036379NICHD NIH HHS P01 HD036379NIDA NIH HHS R01 DA021801
6 · The paper itself

Abstract

The sudden infant death syndrome is associated with a reduction in brainstem serotonin 5-hydroxytryptamine (5-HT) and 5-HT(1A) receptor binding, yet it is unknown if and how these findings are linked. In this study, we used quantitative tissue autoradiography to determine if post-natal development of brainstem 5-HT(1A) receptors is altered in two mouse models where the development of 5-HT neurons is defective, the Lmx1b(f/f/p) , and the Pet-1⁻/⁻ mouse. 5-HT(1A) receptor agonist-binding sites were examined in both 5-HT-source nuclei (autoreceptors) and in sites that receive 5-HT innervation (heteroreceptors). In control mice between post-natal day (P) 3 and 10, 5-HT(1A) receptor binding increased in several brainstem sites; by P25, there were region-specific increases and decreases, refining the overall binding pattern. In the Lmx1b(f/f/p) and Pet-1⁻/⁻ mice, 5-HT(1A)-autoreceptor binding was significantly lower than in control mice at P3, and remained low at P10 and P25. In contrast, 5-HT(1A) heteroreceptor levels were comparable between control and 5-HT-deficient mice. These data define the post-natal development of 5-HT(1A)-receptor binding in the mouse brainstem. Furthermore, the data suggest that 5-HT(1A)-heteroreceptor deficits detected in sudden infant death syndrome are not a direct consequence of a 5-HT neuron dysfunction nor reduced brain 5-HT levels. To elucidate the developmental relationship between serotonin (5-HT) levels and 5-HT(1A) receptors in the brainstem, we examined 5-HT(1A) binding in two 5-HT-deficient mouse models. In nuclei containing 5-HT neurons, 5-HT(1A) binding was decreased (autoreceptors), while binding was maintained in projection sites (heteroreceptors). Thus, brainstem 5-HT(1A)-heteroreceptor-binding sites do not appear developmentally sensitive to reduced brain 5-HT levels.

Indexed as

AgingAnimalsAutoradiographyBinding SitesBrain StemData Interpretation, StatisticalGenotypeLIM-Homeodomain ProteinsMiceMice, KnockoutRaphe NucleiReceptor, Serotonin, 5-HT1ASerotoninTranscription FactorsFev protein, mouseLIM homeobox transcription factor 1 betaLIM-Homeodomain ProteinsReceptor, Serotonin, 5-HT1ASerotoninTranscription FactorsautoreceptorsheteroreceptorsLmx1bPet1raphesudden infant death syndrome

Identifiers

PMID23692315
PMCPMC3987866
OpenAlexW2095409124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.